Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GoodRx Holdings, Inc. Director's Dealing 2021

Jun 14, 2021

31919_dirs_2021-06-14_677ef378-704c-426c-aad3-e1434256b641.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-06-10

Reporting Person: KOSECOFF JACQUELINE B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-10 Class A Common Stock A 6138 $0.00 Acquired 6138 Direct

Footnotes

F1: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 10, 2021 and (ii) the date of the 2022 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.